Haacke, E.M.; Bernitsas, E.; Subramanian, K.; Utriainen, D.; Palutla, V.K.; Yerramsetty, K.; Kumar, P.; Sethi, S.K.; Chen, Y.; Latif, Z.;
et al. A Comparison of Magnetic Resonance Imaging Methods to Assess Multiple Sclerosis Lesions: Implications for Patient Characterization and Clinical Trial Design. Diagnostics 2022, 12, 77.
https://doi.org/10.3390/diagnostics12010077
AMA Style
Haacke EM, Bernitsas E, Subramanian K, Utriainen D, Palutla VK, Yerramsetty K, Kumar P, Sethi SK, Chen Y, Latif Z,
et al. A Comparison of Magnetic Resonance Imaging Methods to Assess Multiple Sclerosis Lesions: Implications for Patient Characterization and Clinical Trial Design. Diagnostics. 2022; 12(1):77.
https://doi.org/10.3390/diagnostics12010077
Chicago/Turabian Style
Haacke, Ewart Mark, Evanthia Bernitsas, Karthik Subramanian, David Utriainen, Vinay Kumar Palutla, Kiran Yerramsetty, Prashanth Kumar, Sean K. Sethi, Yongsheng Chen, Zahid Latif,
and et al. 2022. "A Comparison of Magnetic Resonance Imaging Methods to Assess Multiple Sclerosis Lesions: Implications for Patient Characterization and Clinical Trial Design" Diagnostics 12, no. 1: 77.
https://doi.org/10.3390/diagnostics12010077
APA Style
Haacke, E. M., Bernitsas, E., Subramanian, K., Utriainen, D., Palutla, V. K., Yerramsetty, K., Kumar, P., Sethi, S. K., Chen, Y., Latif, Z., Jella, P., Gharabaghi, S., Wang, Y., Zhang, X., Comley, R. A., Beaver, J., & Luo, Y.
(2022). A Comparison of Magnetic Resonance Imaging Methods to Assess Multiple Sclerosis Lesions: Implications for Patient Characterization and Clinical Trial Design. Diagnostics, 12(1), 77.
https://doi.org/10.3390/diagnostics12010077
